Alert: Glaxosmithkline Reports N2.4 billion Profit (2016 FY)


GSK today released audited results for the financial year ended 31 December 2016.

 

Revenue N’million

FY 2016| N14,385

FY 2015| N15,392

%age change|-7%

 

Profit after tax  N’million

FY 2016| N2,378

FY 2015| N873

%age change|172%

 

EPS (Kobo)

FY 2016|199

FY 2015|86

%age change|131%

 

Download (PDF, 16.02MB)

What's your say?